Sodium nitroprusside (SNP) spontaneously produces nitric oxide (NO). In many cell types, this activates the soluble form of the enzyme guanylyl cyclase (GC), resulting in the elevation of cGMP. We herein report the role of NO and cGMP on iodide uptake in primary cultures of calf thyroid cells. Iodide uptake is the limiting step in thyroid hormone biosynthesis and a typical functional parameter. The effect of SNP on this parameter was thus determined. In cells treated with TSH for 72 h, addition of 5 m SNP for the last 2 h caused a significant inhibition on iodide uptake, with no change in cells not treated with TSH. This action was mimicked by an analogue of cGMP, 8Br-cGMP, and blocked by reduced hemoglobin, thus suggesting that it is mediated by the GC-cGMP pathway. SNP also inhibited the stimulation caused by forskolin or analogues of cAMP, indicating that the effect takes place in this pathway, which would be distal to cAMP generation. The accumulation of radioiodine by thyroid cells is a consequence of the balance between influx and efflux. The studies demonstrate that SNP does not affect iodide efflux, thus revealing that it inhibits the influx.
Introduction
Guanylyl cyclase (GC), which catalyzes the formation of cGMP from GTP, exists in two major forms, the membrane-bound natriuretic peptide receptors and at least one soluble enzyme form (Chinkers & Garbers 1991 , Koesling et al. 1991 . Soluble GCs have attracted much attention recently due to the discovery of nitric oxide (NO), a virtually ubiquitous signaling molecule which exerts many of its biologic effects through cGMP accumulation (Garthwaite 1991 , Moncada et al. 1991 , Snyder & Bredt 1992 . NO is formed from arginine in a reaction catalyzed by the enzyme NO synthase (NOS) (Garthwaite et al. 1988 , Marletta 1993 ), and at least three different isoforms have been identified. Brain (type I) and endothelial (type III) isoforms are constitutive Ca 2+ -calmodulin-dependent enzymes. The type II isoform is an inducible Ca 2+ -independent enzyme that is expressed primarily in cells of the immune system, but is also found in endothelial and vascular smooth muscle cells (Moncada & Higgs 1993) . Expression of mRNAs encoding the three NOS isoforms was readily detected in the rat thyroid gland (Colin et al. 1995) . Moreover, the induction and modulation of NO production by cytokines was reported in primary cultures of human thyrocytes (Kasai et al. 1995) . The existence of constitutive NOS activity and its modulation by carbamylcholine was described in dog thyroid slices (Esteves et al. 1992) . Conversely, there are several reports which demonstrate an increase in cGMP levels after treatment with this muscarinic agonist (Yamashita & Field 1972 , Van Sande et al. 1979 , Brandi et al. 1987 .
The iodination of thyroglobulin is an important step in the formation of thyroid hormones (Nunez 1980) . There is evidence that accumulation of iodide within the follicular lumen is a prerequisite for the iodination reaction (Ekholm 1981) . This is accomplished by a series of steps regulated by TSH, which include both movement of iodide from the bloodstream into the cell (influx) and out of the cell into the follicular lumen (efflux) (Dumont & Lamy 1980) . The effects of NO-cGMP on iodine organification and T 3 secretion by human thyroid cells were investigated (Millatt et al. 1993 , Kasai et al. 1995 . Whether NO can regulate iodide uptake has not yet been determined. In the present work we therefore investigated the role of NO in iodide uptake.
Materials and Methods

Materials
Bovine TSH (SA 2 IU per mg protein), other hormones and chemicals were purchased from Sigma Chemical Co (St Louis, MO, USA). The protein kinase G inhibitor was purchased from Calbiochem (San Diego, CA, USA). cGMP antiserum was purchased from Chemicon Int (La Jolla, CA, USA).
Cell cultures
Calf thyroids were obtained at a local slaughterhouse, transported to the laboratory in ice-cold saline containing 100 U/ml penicillin and 100 µg/ml streptomycin and processed within 2 h after killing. The glands were carefully dissected, trimmed and digested, under sterile conditions, in medium 199 plus sodium bicarbonate 2·2 mg/ml; amphotericin B 2·5 µg/ml; penicillin 100 U/ ml and streptomycin 100 µg/ml, containing 1 mg/ml collagenase type 1A and DNAse 20 µg/ml, in a ratio of 10 ml/g tissue. At least five glands from different animals were digested each time. The digestion was carried out at 37 C with shaking during 90 min. The digested material was filtered through sterile cheese cloth and centrifuged at 2 000 r.p.m. during 30 s in order to obtain thyroid follicles. The precipitate was washed several times with medium supplemented with 10% fetal calf serum (FCS). The follicles thus obtained were resuspended in growth medium (medium 199 containing 5% FCS; 5 µg/ml transferrin and 2·5 µg/ml insulin) and seeded in culture plates.
The cells were kept under these conditions for 48 h, and the medium was then replaced by one containing 0·1% FCS until cells reached confluency. The medium was changed every 4 days and the cells were cultured at 37 C under an atmosphere of 95% air and 5% CO 2 in a humidified incubator. The cells reached confluence after 7 days. All the experiments were performed with confluent cells and the compounds tested were dissolved in the same culture medium.
I Uptake
After the corresponding treatments, the cells were placed in 24-well plates and washed with PBS. Dulbecco modified Eagle medium (0·5 ml) containing 1 µ KI, 1 m methylmercaptoimidazole (MMI) and 1 µCi/ml 125 I, was added to each well. The cells were incubated at 37 C during 120 min and the reaction was terminated by discarding the medium and washing three times with cold PBS containing 1 µ KI. The cells were resuspended in 0·5 ml 0·1  NaOH, 2 m EDTA. The radioactivity of each well was counted in an automatic gamma counter, and the results were expressed as pmol iodide/mg protein.
I Efflux
The confluent cells were incubated with radioiodine as described above, during 2 h. At this time the medium was replaced by 0·5 ml MEM containing 1 µ KI (zero time). Medium was replaced every 2 min. The radioactivity of each sample and that remaining in the cell at the end of the study were determined. For this purpose the cells were re-suspended as described above. The efflux was calculated as a percentage of total intracellular radioactivity at zero time.
Cyclic GMP determination
Cells were grown to confluence in 35 mm diameter plates. After the corresponding treatments in the presence of 0·5 m isobutyl-methyl-xanthine, the media were removed and 100 µl absolute ethanol were added in order to extract the cyclic nucleotide. The ethanol extracts were evaporated at 45 C and the residue was re-suspended in 500 µl 50 m Na acetate buffer (pH 5·5). Cyclic nucleotide was measured according to the RIA described by Steiner et al. (1972) . Results are expressed as pmoles nucleotide/mg protein and are the average of between four and six experiments run in quadriplicate.
Other assays
Protein was determined according to Lowry et al. (1951) .
Statistical analysis
Data are presented as means ... Statistical evaluation of experimental data was performed using analysis of variance followed by Dunnet's and Student's t tests. Differences were considered significant for P<0·05.
Results
Previous results from our laboratory have shown that GC exists in the calf thyroid as a main fraction of soluble enzyme and a small amount bound to membranes (particulate). Conversely, we have demonstrated the presence of the soluble enzyme in primary cell cultures and its possible modulation by sodium nitroprusside (SNP) (Bocanera LV, Martinetto H, Flawia MM & Piserev MA, unpublished data).
Since SNP stimulates GC activity, we examined its effect on iodide uptake, to establish the role of this pathway in the regulation of a functional thyroid parameter. TSH stimulated the iodide uptake system in these cells at 72 h. When confluent cells maintained for 72 h under basal conditions (without TSH) were treated with 5 m SNP for different times (20, 60, 120 and 180 min), non significant changes in 125 I uptake were observed (Fig. 1) . Incubation with 0·5 mU/ml TSH for 72 h increased this parameter by around 260% (P<0·01 vs control). The effect of TSH was not altered at 20 and 60 min after SNP addition but at 180 min the stimulation caused by the hormone decreased from 242% to 85% (an inhibition of 65%, P<0·01) (Fig. 1) .
The inhibitory effect of SNP on TSH-induced iodide uptake was dose-dependent, reaching a maximum at 5 m (Fig. 2) .
In order to exclude the possibility that the inhibition of iodide uptake was due to a toxic effect of SNP, the following study was performed. Confluent cells maintained with TSH for 72 h and then incubated with SNP for 3 h were washed by removal of the medium containing the nitrogenous compound and reincubated in buffer with TSH alone for a further 24 h. When at this time the 125 I uptake was assayed, the inhibitory effect of SNP on the ability of TSH to increase iodide uptake was seen to disappear (Fig. 3) .
In an attempt to evaluate if SNP was capable of exerting its effect through NO, SNP inhibition was measured after the simultaneous incubation of the cells with SNP and reduced hemoglobin (0·1 m). The hemoglobin captured the NO released from SNP and abolished the ability of nitroprusside to inhibit the action of TSH (Fig. 4) .
cGMP is the second messenger mediating the SNP effect. We therefore examined the effect of SNP on the accumulation of cGMP in control and TSH-stimulated cells. When SNP was added to cells, a time-dependent increase in cGMP was observed, reaching a maximum at 30 min regardless of treatment with TSH (Fig. 5) .
Since SNP stimulates cGMP formation and inhibits TSH-stimulated iodide uptake, the action of 8Br-cGMP on the latter was analyzed. Cells treated with TSH for 72 h showed an increase in 125 I uptake. Addition of 10 m 8Br-cGMP for 20 min did not alter either basal or TSH-stimulated uptake, while a significant inhibition of TSH action was observed after 60 min treatment with the cyclic nucleotide (Fig. 6 ).
Several findings suggest that cGMP acts by increasing protein kinase G (PKG) activity ( Jin et al. 1993 , Robertson et al. 1993 , McKee et al. 1994 . To study whether the action of SNP upon iodide uptake, stimulated by TSH, involves this mechanism, we measured the halogen influx in the presence of 10 m KT5823 (PKG inhibitor). Figure 7 shows that KT5823 blocked the action of SNP in the presence of TSH without any change in the basal conditions.
In order to determine whether the inhibitory effect of SNP occurs through the adenylate cyclase (AC)-cAMP pathway, the cells were treated with forskolin and the cAMP analog, 8Br-cAMP, which mimics the effect of TSH. Incubation of the cells with these compounds during 72 h caused a significant increase in 125 I uptake. When 5 m SNP was added during the last 3 h a significant inhibition of forskolin and 8Br-cAMP action was observed (Fig. 8) .
The ability of SNP to decrease TSH-stimulated 125 I accumulation could reflect an action of SNP to increase iodide efflux from the cell. In order to test this possibility, cells were treated with 0·5 mU/ml TSH during 72 h and with 5 m SNP for the last 180 min, and iodide efflux was measured. As shown in Fig. 9 non significant changes were observed in the rate of iodide efflux.
Discussion
It is generally accepted that TSH stimulation of several differentiated functions in thyroid cells, such as iodide Figure 1 Effect of SNP and TSH on iodide uptake. Confluent cells were treated with or without 0·5 mU/ml TSH for 72 h; 5 mM SNP or both compounds for the indicated time. Iodide uptake was measured as described in Materials and Methods. Each value is the mean S.E.M. of six different experiments. *P<0·01 vs control; **P<0·01 vs TSH.
Figure 2
Effect of SNP on TSH-stimulated iodide uptake: dose-response. Cells were treated with TSH (0·5 mU/ml) for 72 h, followed by incubation with SNP at different concentrations during 3 h. The iodide uptake was determined as described in Materials and Methods. Each value is the mean S.E.M. of three experiments. *P<0·05; **P<0·001 vs control.
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Journal of Endocrinology (1997) 155, 451-457 uptake, thyroglobulin biosynthesis and thyroid hormone release, requires an increase in AC activity and intracellular cAMP content . It is well known that factors other than TSH are potent modulators of growth and differentiated functions in thyroid cells. Previous evidence has shown, in thyroid cells, the existence of NOS activity and NO-mediated cGMP formation (Esteves et al. 1992 , Millatt et al. 1993 , Colin et al. 1995 . Morever, GC activity has been found in rat thyroid tissue (Barmasch et al. 1973) and cGMP can influence different thyroid parameters (Pisarev et al. 1971 , De Nayer 1973 .
The results of the present study further support the existence of this metabolic pathway in the thyroid gland. SNP, a well known source of NO (Bates et al. 1991) increases GC activity and cGMP production in primary bovine thyrocytes.
In these first studies, we investigated the role of this system in iodide uptake modulation. According to present knowledge, TSH stimulates, after several hours of treatment, iodide transport through the AC-cAMP pathway (Gérard et al. 1989 , Weiss et al. 1984 , Carrasco 1993 ). This finding is in keeping with our results, since, under the present conditions, TSH first increased iodide uptake significantly at 24 h, reaching a maximum at 72 h (data not shown), and this effect was inhibited by SNP. This compound inhibited the iodide uptake in a time and dosedependent manner. The optimum concentration of SNP which produces the inhibition on this process showed a high correlation with the dose necessary to obtain maximum GC activity. The nitrogenous compound increased the cGMP level in basal and TSH-stimulated conditions. These results were consistent with previous reports (Katsuki et al. 1977 , Gerzer et al. 1988 , Okamoto 1988 , Millatt et al. 1993 ) in many cell types, including thyroid cells. The lack of effect of TSH on cGMP production confirms the findings of other workers (Decoster & Dumont 1985 , Yamashita & Field 1992 , Millatt et al. 1993 . In addition, cGMP decreased the effect of thyrotropin on iodide uptake, suggesting that the inhibition of iodide uptake caused by SNP is mediated by this cyclic nucleotide. These results suggest that GC is involved in the mechanism of inhibition by SNP.
Our observation that the inhibitory effect of SNP could be reversed after washing the cells would indicate a lack of toxic effect. Furthermore, the basal levels of iodide uptake did not vary in the presence of SNP.
Because of the natural affinity of NO for heme rings (Gibson & Roughton 1957) , free reduced hemoglobin has been used as an inhibitor of SNP action. Reversal of the SNP effect by hemoglobin, indicates that it is mediated by NO release.
The data presented above support the following: 1) SNP, an NO donor, increases GC activity and enhances cGMP accumulation.
2) 8Br-cGMP, a permeable cGMP analog, mimics the effect of SNP.
3) Hemoglobin reverses the SNP effect.
Figure 3
Reversal of SNP inhibitory effect on iodide uptake. Cells incubated with TSH (0·5 mU/ml) for 72 h were treated with SNP (5 mM) for 3 h. After washing twice with fresh medium, the cultures were re-incubated in the presence of medium plus 0·5 mU/ml TSH during 24 h. The iodide uptake was assayed before and after the reversible process. Each value is the mean S.E.M. of four experiments. *P<0·01 vs control; **P<0·01 vs TSH. This suggests that SNP, generating NO, increases cGMP levels, which in turn acts on iodide uptake. However, the existence of an alternative mechanism cannot be excluded.
The results obtained with the PKG inhibitor (KT5823), i.e. reversal of the SNP action, support the idea that NO enhances cGMP intracellular concentrations, with the ensuing PKG activation.
TSH and/or cAMP analogs enhanced iodide uptake in thyroid cells thus supporting the role of cAMP in the induction of the synthesis of the iodide porter and in the increase of halogen uptake (Carrasco 1993) . Forskolin and 8Br-cAMP reproduced the effect of TSH, and SNP inhibited their action. SNP did not inhibit TSHstimulated cAMP levels in our system (data not shown), thus excluding an effect at this point. Therefore we may conclude that the inhibition of this process takes place beyond the cAMP production pathway. It is clear that the iodide influx was sensitive to SNP action when the cells were previously treated with TSH or other compounds capable of increasing cAMP levels.
There were no effects of SNP on the halogen efflux, indicating that the point of action of this compound probably lies in the iodide influx mechanisms.
In the experiments described above, we used SNP as a pharmacological stimulator of the NO-GC-cGMP system. In the thyroid gland the possible physiologic mechanism that stimulates this pathway remains 
Figure 6
Effect of 8Br-cGMP on TSH-stimulated iodide uptake. Confluent cells were treated in presence or absence of TSH (0·5 mU/ml) for 72 h and then exposed to 10 mM 8Br-cGMP during 20 (white bars) and 60 (grey bars) min. Each value is the mean S.E.M. of four experiments. *P<0·01 vs control; **P<0·01 vs TSH.
Figure 7
Effect of the PKG inhibitor KT5823 on SNP action. Cells were exposed to TSH (T, 0·5 mU/ml) for 72 h; SNP (5 mM) and KT5823 (KT, 10 M) were then added during 3 h. Assays were performed as described in Materials and Methods. Each value isspeculative. In dog thyroid, it has been demonstrated that NOS activity is stimulated by carbamylcholine (Esteves et al. 1992) . Other studies report that the cyclic GMP levels are increased by acetylcholine and carbamylcholine (Van Sande et al. 1975 , 1979 . These results suggest that NO production in thyroid cells would be under the control of the cholinergic system. Aiyoshi et al. (1978) , showed that the concentration of intracellular cGMP is increased by the action of norepinephrine, depending on the presence of extracellular calcium. NOS activation is highly dependent on Ca ++ concentration. We can therefore postulate that this increase of intracellular cGMP, produced by norepinephrine, is related to NOS activation. On the other hand, Kasai et al. (1995) , report on the induction and modulation of NO production by cytokines in primary cultures of human thyrocytes. Finally, as NO diffuses easily, we can not discard the possibility that the NO produced by macrophage and endothelial cells can gain access to the thyrocytes and activate GC.
Although TSH plays a major role in the regulation of thyroid physiology, compounds other than TSH are also modulators of growth and differentiated functions, still modifying the thyrotropin response. NO and cGMP appear to modulate, as least partially, the TSH stimulation of iodide uptake. Further studies will better define the control of cellular function in the thyroid. and M A P are established researchers; D S is a fellow from CONICET). L B P is a Fellow from the Comisión de Investigaciones Científicas de la Provincia de Buenos Aires.
